(VIANEWS) – Alamos Gold (AGI), AppFolio (APPF), Terreno Realty Corporation (TRNO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Alamos Gold (AGI)
27.8% sales growth and 7.12% return on equity
Alamos Gold Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and extraction of gold deposits in North America. It also explores for silver and precious metals. The company's flagship project is the Young-Davidson mine, which includes contiguous mineral leases and claims totaling 11,000 acres located in Northern Ontario, Canada. It also holds interests in a portfolio of development stage projects in Turkey, Canada, Mexico, and the United States. The company was formerly known as AuRico Gold Inc. and changed its name to Alamos Gold Inc. in July 2015. The company was incorporated in 2003 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Alamos Gold has a trailing twelve months EPS of $0.52.
PE Ratio
Alamos Gold has a trailing twelve months price to earnings ratio of 29.99. Meaning, the purchaser of the share is investing $29.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.12%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 13, 2024, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 0.64%.
Sales Growth
Alamos Gold’s sales growth is 7.5% for the present quarter and 27.8% for the next.
Volume
Today’s last reported volume for Alamos Gold is 252312 which is 89.24% below its average volume of 2344950.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 1.05B for the twelve trailing months.
2. AppFolio (APPF)
24.7% sales growth and 26.38% return on equity
AppFolio, Inc., together with its subsidiaries, provides industry-specific cloud-based business software solutions, services, and data analytics for the real estate industry. The company offers AppFolio Property Manager, a property management solution designed to address the operational and business requirements of property management companies and their business ecosystems; and AppFolio Investment Management, a cloud-based software solution for real estate investment managers of various sizes that provide tools and services designed to streamline their real estate investment management businesses. It also provides Value+ services that are designed to enhance, automate, and streamline processes and workflows for property management businesses, such as artificial intelligence leasing assistant, tenant screening, electronic payment, utility management, maintenance contact center, tenant debt collection, and mailing services. AppFolio, Inc. was incorporated in 2006 and is headquartered in Santa Barbara, California.
Earnings Per Share
As for profitability, AppFolio has a trailing twelve months EPS of $2.11.
PE Ratio
AppFolio has a trailing twelve months price to earnings ratio of 111.64. Meaning, the purchaser of the share is investing $111.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.38%.
3. Terreno Realty Corporation (TRNO)
12.2% sales growth and 5.43% return on equity
Terreno Realty Corporation (“Terreno”, and together with its subsidiaries, the “Company”) acquires, owns and operates industrial real estate in six major coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. All square feet, acres, occupancy and number of properties disclosed in these notes to the consolidated financial statements are unaudited. As of December 31, 2023, the Company owned 259 buildings aggregating approximately 16.0 million square feet, 45 improved land parcels consisting of approximately 152.4 acres, seven properties under development or redevelopment and approximately 62.7 acres of land entitled for future development. The Company is an internally managed Maryland corporation and elected to be taxed as a real estate investment trust (“REIT”) under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2010.
Earnings Per Share
As for profitability, Terreno Realty Corporation has a trailing twelve months EPS of $1.92.
PE Ratio
Terreno Realty Corporation has a trailing twelve months price to earnings ratio of 31.59. Meaning, the purchaser of the share is investing $31.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.43%.
Moving Average
Terreno Realty Corporation’s worth is above its 50-day moving average of $56.78 and above its 200-day moving average of $58.99.
4. International General Insurance Holdings Ltd. (IGIC)
11.5% sales growth and 24.75% return on equity
International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance segments. It offers a portfolio of specialty lines insurance products and services for energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine liability, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.
Earnings Per Share
As for profitability, International General Insurance Holdings Ltd. has a trailing twelve months EPS of $2.68.
PE Ratio
International General Insurance Holdings Ltd. has a trailing twelve months price to earnings ratio of 5.22. Meaning, the purchaser of the share is investing $5.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.75%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 483.96M for the twelve trailing months.
Sales Growth
International General Insurance Holdings Ltd.’s sales growth is 9.3% for the ongoing quarter and 11.5% for the next.
5. Vertex Pharmaceuticals (VRTX)
8.2% sales growth and 24.38% return on equity
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Vertex Pharmaceuticals has a trailing twelve months EPS of $13.89.
PE Ratio
Vertex Pharmaceuticals has a trailing twelve months price to earnings ratio of 28.55. Meaning, the purchaser of the share is investing $28.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.38%.
Volume
Today’s last reported volume for Vertex Pharmaceuticals is 1164750 which is 7.99% below its average volume of 1265930.
Moving Average
Vertex Pharmaceuticals’s worth is way below its 50-day moving average of $448.10 and under its 200-day moving average of $407.31.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 10.18B for the twelve trailing months.
6. SM Energy Company (SM)
6.2% sales growth and 21.67% return on equity
Investors interested in the energy sector might look at some better-ranked stocks like Sunoco LP (SUN Quick QuoteSUN – Free Report) and SM Energy Company (SM Quick QuoteSM – Free Report) , each sporting a Zacks Rank #1 (Strong Buy) andCoterra Energy Inc. (CTRA Quick QuoteCTRA – Free Report) , carrying a Zacks Rank #2 (Buy), at present.
SM Energy Company, an independent energy company, engages in the acquisition, exploration, development, and production of oil, gas, and natural gas liquids in the state of Texas. It has working interests in oil and gas producing wells in the Midland Basin and South Texas. The company was formerly known as St. Mary Land & Exploration Company and changed its name to SM Energy Company in May 2010. SM Energy Company was founded in 1908 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, SM Energy Company has a trailing twelve months EPS of $6.37.
PE Ratio
SM Energy Company has a trailing twelve months price to earnings ratio of 6.85. Meaning, the purchaser of the share is investing $6.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.67%.
Sales Growth
SM Energy Company’s sales growth is 11.9% for the current quarter and 6.2% for the next.
Previous days news about SM Energy Company(SM)
- According to Zacks on Monday, 8 July, "Meanwhile, investors interested in the energy sector might consider operators like SM Energy Company (SM Quick QuoteSM – Free Report) , Sunoco LP (SUN Quick QuoteSUN – Free Report) and Tullow Oil (TUWOY Quick QuoteTUWOY – Free Report) . "
7. Brinks Company (BCO)
6% sales growth and 23.33% return on equity
The Brink's Company provides secure transportation, cash management, and other security-related services in North America, Latin America, Europe, and internationally. The company offers armored vehicle transportation of valuables; automated teller machine (ATM) management services, such as cash replenishment, replenishment forecasting, cash optimization, ATM remote monitoring, service call dispatching, transaction processing, installation, and first and second line maintenance services; network infrastructure; and cash-in-transit services. It also provides transportation services for diamonds, jewelry, precious metals, securities, bank notes, currency, high-tech devices, electronics, and pharmaceuticals; vault outsourcing and money processing services; and services related to deploying and servicing intelligent safes and safe control devices, as well as cashier balancing, counterfeit detection, account consolidation, electronic reporting, check imaging, and reconciliation services. In addition, the company offers technology applications, including online cash tracking, cash inventory management, and other web-based tools. Further, it provides bill payment acceptance and processing services; prepaid cards and corporate debit cards; and security system design and installation services that include alarms, motion detectors, closed-circuit televisions, and digital video recorders, as well as access control systems comprising card and biometric readers, electronic locks, and turnstiles. Additionally, the company offers monitoring services; and security and guarding services to protect airports, offices, warehouses, stores, and public venues. It serves banks and financial institutions, retailers, government agencies, mints, jewelers, and other commercial operations. The company was formerly known as The Pittston Company and changed its name to The Brink's Company in May 2003. The Brink's Company was founded in 1859 and is headquartered in Richmond, Virginia.
Earnings Per Share
As for profitability, Brinks Company has a trailing twelve months EPS of $2.62.
PE Ratio
Brinks Company has a trailing twelve months price to earnings ratio of 38.47. Meaning, the purchaser of the share is investing $38.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.33%.
Volume
Today’s last reported volume for Brinks Company is 232201 which is 10.19% below its average volume of 258570.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 10, 2024, the estimated forward annual dividend rate is 0.97 and the estimated forward annual dividend yield is 0.95%.
Yearly Top and Bottom Value
Brinks Company’s stock is valued at $100.79 at 11:22 EST, under its 52-week high of $105.50 and way higher than its 52-week low of $63.79.
